Subscribe to RSS
DOI: 10.1055/s-0028-1087562
New Efficient Synthesis of 5-Ethoxyoxazoles and Oxazolo[3,2-c]quinazolines via Aza-Wittig Reaction
Publication History
Publication Date:
16 February 2009 (online)
Abstract
5-Ethoxyoxazoles or 2-acylamino propanoates were synthesized by aza-Wittig reaction of iminophosphorane with acyl chloride in the presence of triethylamine. Reactions of 5-alkoxyoxazole with triphenyphosphine produced iminophosphoranes. A tandem aza-Wittig reaction of iminophosphorane with isocyanate or carbon disulfide generated oxazolo[3,2-c]quinazolines in satisfactory yields.
Key words
oxazole - oxazolo[3,2-c]quinazoline - aza Wittig reaction - carbodiimide - imidoyl chloride
- Supporting Information for this article is available online:
- Supporting Information
-
1a
Palmer DC.Venkatraman S. Oxazoles: Synthesis, Reactions, and Spectroscopy Part A: John Wiley; New York: 2003. p.1-390 -
1b
Wasserman HH.McCarthy KE.Prowse KS. Chem. Rev. 1986, 86: 845 -
1c
Hartner FW. In Comprehensive Heterocyclic Chemistry II Vol. 3:Shinkai I. Pergamon; Oxford UK: 1996. p.262-318 - 2
Jacobi PA.Lee K. J. Am. Chem. Soc. 1997, 119: 3409 -
3a
Doyle KJ.Moody CJ. Tetrahedron 1994, 50: 3761 -
3b
Moody CJ.Bagley MC. Synlett 1998, 361 -
3c
Ducept PC.Marsden SP. Synlett 2000, 692 -
4a
Huang W.-S.Zhang Y.-X.Yuan C.-Y. Synth. Commun. 1996, 26: 1149 -
4b
Bossio R.Marcaccini S.Pepino R. Heterocycles 1986, 24: 2003 -
5a
Jacobi PA.Kaczmarek CSR.Udodong UES. Tetrahedron 1987, 43: 5475 -
5b
Nahm S.Weinreb SM. Tetrahedron Lett. 1981, 22: 3815 -
5c
Collins DJ.Hughes TC.Johnson WM. Aust. J. Chem. 1996, 49: 463 -
6a
Chan J.Faul M. Tetrahedron Lett. 2006, 47: 3361 -
6b
Palacios F.Herran E.Alonso C.Rubiales G.Lecea B.Ayerbe M.Cossio FP. J. Org. Chem. 2006, 71: 6020 -
6c
Lertpibulpanya D.Marsden SP.Rodriguez-Garcia I.Kilner CA. Angew. Chem. Int. Ed. 2006, 45: 5000 -
6d
Palacios F.Alonso C.Aparicio D.Rubiales G.Santos JM. Tetrahedron 2007, 63: 523 -
6e
Zanatta N.Schneider JMFM.Schneider PH.Wouters AD.Bonacorso HG.Martins MAP.Wessjohann LA. J. Org. Chem. 2006, 71: 6996 - 7
Takeuchi H.Yanagida S.Ozaki T.Hagiwara S.Eguchi S. J. Org. Chem. 1989, 54: 431 - 8
Molina P.Fresneda PM.Almendros P. Heterocycles 1993, 36: 2255 - 9
Zbiral E.Bauer E.Stroh J. Monatsh. Chem. 1971, 102: 168 -
10a
Ding MW.Xu SZ.Zhao JF. J. Org. Chem. 2004, 69: 8366 -
10b
Zhao JF.Xie C.Xu SZ.Ding MW.Xiao WJ. Org. Biomol. Chem. 2006, 4: 130 -
10c
Yuan JZ.Fu BQ.Ding MW.Yang GF. Eur. J. Org. Chem. 2006, 4170 -
10d
Ding MW.Fu BQ.Cheng L. Synthesis 2004, 1067 -
10e
Li HX.Xie C.Ding MW.Liu ZM.Yang GF. Synlett 2007, 2280 -
10f
Liu MG.Hu YG.Ding MW. Tetrahedron 2008, 64: 9052
References and Notes
Oxazoles 4 and
2-Acylaminopropanoates 5
To a stirred solution of
azide 1 (1.0 mmol) in CH2Cl2 (10 mL)
was added a solution of Ph3P (0.26 g, 1 mmol) in dry CH2Cl2 (5
mL) at r.t. After the reaction mixture was stirred for 2 h, acyl
chloride (1.0 mmol) and Et3N (0.30 g, 3.0 mmol) were
added at r.t., and the color of the solution turned yellow. After
stirring for 4 h, the mixture was filtered to remove the Et3NHCl,
and the filtrate was evaporated under reduced pressure. The crude
product was purified by flash chromatography (5:1, PE-Et2O)
to yield oxazoles 4 or
2-acylaminopropanoates 5.
Spectral
Data for Some Unreported Compounds
Compound 4c: light yellow solid, mp 60-61 ˚C.
IR (KBr): 1620, 1487, 1282, 1093, 1005 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 7.68-7.21
(m, 4 H, ArH), 6.05 (s, 1 H, ArH), 4.00 (q, J = 7.2
Hz, 2 H, OCH2), 1.30 (t, J = 7.0
Hz, 3 H, CH3). ¹³C NMR (100
MHz, CDCl3): δ = 159.5,
150.9, 134.8, 128.5, 128.4, 126.2, 125.9, 125.7, 100.3, 100.1, 67.6,
14.2, 14.0. MS: m/z (%) = 223
(90) [M+], 195 (73), 167 (23),
139 (100), 111 (64). Anal. Calcd. for C11H10ClNO2:
C, 59.07; H, 4.51; N, 6.26. Found: C, 59.01; H, 4.61; N, 6.44.
Compound 4d: white solid, mp 52-54 ˚C.
IR (KBr): 1613, 1503, 1282, 1222, 1046, 1008 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 7.91-7.07
(m, 4 H, ArH), 6.18 (s, 1 H, ArH), 4.20-4.13 (m, 2 H, OCH2),
1.48-1.43 (m, 3 H, CH3).
¹³C
NMR (100 MHz, CDCl3): δ = 164.1,
161.7, 159.4, 151.0, 126.9, 126.5, 123.6, 115.5, 115.3, 115.2, 114.9, 100.1,
99.7, 67.7, 67.4, 67.2, 13.9, 13.8. MS: m/z (%) = 207 (71) [M+],
178 (45), 151 (36), 134 (17), 123 (100), 107 (25). Anal. Calcd for
C11H10FNO2: C, 63.76; H, 4.86;
N, 6.76. Found: C, 63.50; H, 4.98; N, 6.71.
Compound 4e: white solid, mp 46-47 ˚C.
IR (KBr): 1613, 1503, 1279, 1099, 1046, 1008 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 7.81-7.21
(m, 4 H, ArH), 6.18 (s, 1 H, ArH), 4.16 (q, J = 7.2
Hz, 2 H, OCH2), 2.37 (s, 3 H, CH3), 1.45 (t, J = 7.2 Hz,
3 H, CH3). ¹³C NMR (100
MHz, CDCl3): δ = 159.4,
152.7, 139.5, 129.3, 129.2, 125.2, 125.0, 124.8, 100.4, 100.1, 67.9,
21.4, 21.2, 14.5, 14.3. MS: m/z (%) = 203 (14) [M+],
174 (5), 147 (13), 119 (100), 91 (20). Anal. Calcd for C12H13NO2:
C, 70.92; H, 6.45; N, 6.89. Found: C, 70.80; H, 6.60; N, 6.76.
Compound 4f: white solid, mp 51-52 ˚C.
IR (KBr): 1616, 1506, 1254, 1024 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 7.84
(d, J = 8.8
Hz, 2 H, ArH), 6.91 (d, J = 8.8
Hz, 2 H, ArH), 6.15 (s, 1 H, ArH), 4.10 (q, J = 7.2
Hz, 2 H, OCH2), 3.78 (s, 3 H, OCH3), 1.41
(t, J = 7.2
Hz, 3 H, CH3). ¹³C NMR (100
MHz, CDCl3): δ = 160.3,
159.1, 152.2, 126.5, 120.1, 113.7, 99.9, 67.6, 54.8, 14.1. MS: m/z (%) = 219
(24) [M+], 190 (20), 163 (3),
135 (100), 118 (3), 107 (6). Anal. Calcd for C12H13NO3:
C, 65.74; H, 5.98; N, 6.39. Found: C, 65.67; H, 6.05; N, 6.44.
Compound 4g: white solid, mp 50-51 ˚C.
IR (KBr): 1601, 1556, 1481, 1282, 1043, 1005 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 7.86-7.28
(m, 4 H, ArH), 6.18 (s, 1 H, ArH), 4.13 (q, J = 7.0
Hz, 2 H, OCH2), 1.42 (t, J = 7.0
Hz, 3 H, CH3). ¹³C NMR (100
MHz, CDCl3): δ = 159.7,
150.6, 134.4, 129.7, 129.0, 124.9, 122.9, 100.6, 67.8, 14.2. MS: m/z (%) = 223
(19) [M+], 195 (22), 167 (16),
139 (100). Anal. Calcd for C11H10ClNO2:
C, 59.07; H, 4.51; N, 6.26. Found: C, 59.19; H, 4.70; N, 6.32.
Compound 4h: white solid, mp 45-46 ˚C.
IR (KBr): 1610, 1497, 1478, 1282, 1229, 1043, 1027 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 7.91-7.11
(m, 4 H, ArH), 6.27 (s, 1 H, ArH), 4.16 (q, J = 7.0
Hz, 2 H, OCH2), 1.43 (t, J = 7.0
Hz,
3 H, CH3). ¹³C
NMR (100 MHz, CDCl3): δ = 160.4,
159.6, 157.9, 148.3, 130.7, 130.6, 128.1, 123.9, 116.4, 116.2, 115.5,
115.4, 100.4, 67.7, 14.1. MS: m/z (%) = 207
(16) [M+], 179 (13), 151 (6),
123 (100), 95 (22). Anal. Calcd for C11H10FNO2:
C, 63.76; H, 4.86; N, 6.76. Found: C, 63.70; H, 4.98; N, 6.83.
Compound 4i: light yellow solid, mp 52-54 ˚C.
IR (KBr): 2130 (N3), 1610 (C=O), 1594, 1493,
1304, 1285, 1033, 1005 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 7.88-7.17
(m, 4 H, ArH), 6.28 (s, 1 H, ArH), 4.19 (q, J = 7.0
Hz, 2 H, OCH2), 1.47 (t, J = 7.0
Hz, 3 H, CH3). MS: m/z (%) = 230
(50) [M+], 202 (39), 173 (55),
145 (57), 118 (29), 90 (100). Anal. Calcd for C11H10N4O2:
C, 57.39; H, 4.38; N, 24.34. Found: C, 57.45; H, 4.50; N, 24.49.
Compound 4k: light yellow oil. ¹H
NMR (600 MHz, CDCl3): δ = 7.80-7.21
(m, 4 H, ArH), 4.22 (q, J = 7.0
Hz,
2 H, OCH2), 2.37 (s, 3 H, CH3),
2.11 (s, 3 H, CH3), 1.40 (t, J = 7.2
Hz, 3 H, CH3). MS: m/z (%) = 217
(5) [M+], 136 (2), 119 (62),
91 (100).
Compound 4l: white solid,
mp 83-85 ˚C. ¹H NMR (600 MHz,
CDCl3): δ = 7.85-7.37
(m, 4 H, ArH), 4.23 (q, J = 7.2 Hz,
2 H, OCH2), 2.11 (s, 3 H, CH3), 1.40 (t, J = 7.2 Hz,
3 H, CH3). MS: m/z (%) = 237
(75) [M+], 207 (13), 138 (100), 110
(43). Anal. Calcd for C12H12ClNO2:
C, 60.64; H, 5.09; N, 5.89. Found: C, 60.47; H, 5.24; N, 5.95.
Compound 5a: white solid, mp 76-77 ˚C.
IR (KBr): 3347 (NH), 1749 (C=O), 1642, 1528, 1493, 1213,
1181 cm-¹. ¹H NMR
(400 MHz, CDCl3): δ = 7.82-7.42
(m, 5 H, ArH), 6.84 (d, J = 6.4
Hz, 1 H, NH), 4.82-4.76 (m, 1 H, NCH), 4.24 (q, J = 7.0 Hz,
2 H, OCH2), 1.52 (d, J = 6.8
Hz, 3 H, CH3), 1.31 (t, J = 7.2
Hz, 3 H, CH3). ¹³C NMR (100
MHz, CDCl3): δ = 173.2,
166.7, 133.9, 131.6, 128.5, 127.0, 61.6, 48.5, 18.6, 14.1. MS: m/z (%) = 221
(4) [M+], 148 (66), 105 (100), 77
(24). Anal. Calcd for C12H15NO3:
C, 65.14; H, 6.83; N, 6.33. Found: C, 65.33; H, 6.98; N, 6.43.
Compound 5b: white solid, mp 117-118 ˚C.
IR (KBr): 3290 (NH), 1742 (C=O), 1635, 1556, 1203, 1162,
1024 cm-¹.
¹H
NMR (400 MHz, CDCl3): δ = 7.72-7.23
(m, 4 H, ArH), 6.75 (d, J = 6.8
Hz, 1 H, NH), 4.82-4.74 (m, 1 H, NCH), 4.24 (q, J = 7.2 Hz,
2 H, OCH2), 2.40 (s, 3 H, CH3), 1.52 (d, J = 7.2 Hz,
3 H, CH3), 1.31 (t, J = 7.2
Hz, 3 H, CH3).
MS: m/z (%) = 235
(6) [M+], 162 (29), 119 (100),
91 (13). Anal. Calcd for C13H17NO3:
C, 66.36; H, 7.28; N, 5.95. Found: C, 66.44; H, 7.40; N, 5.99.
Compound 5c: white solid, mp 98-99 ˚C.
IR (KBr): 3293 (NH), 1742, 1626, 1544, 1487, 1216, 1166, 1093, 1017
cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 7.75
(d, J = 8.4
Hz, 2 H, ArH), 7.40 (d, J = 8.4
Hz, 2 H, ArH), 6.84 (br, 1 H, NH), 4.80-4.72 (m, 1 H, NCH),
4.25 (q, J = 7.2
Hz, 2 H, OCH2), 1.52 (d, J = 7.2
Hz, 3 H, CH3), 1.32 (t, J = 7.2
Hz, 3 H, CH3). MS: m/z (%) = 255
(4) [M+], 182 (68), 139 (100),
111 (14). Anal. Calcd for C13H17NO3:
C, 56.37; H, 5.52; N, 5.48. Found: C, 56.45; H, 5.78; N, 5.59.
Iminophosphorane 6 To a stirred solution of 4i (1.15 g, 5 mmol) in CH2Cl2 (15 mL) was added a solution of Ph3P (1.31 g, 5 mmol) in dry CH2Cl2 (10 mL). After the reaction mixture was stirred for 2 h, the solvent was removed under reduced pressure, and the residue was recrystallized from Et2O and EtOH (1:1; v/v) to give the iminophosphorane 6 (2.22 g, yield 96%); light yellow crystals; mp 175-177 ˚C. IR (KBr): 1606, 1468, 1435, 1353, 1271, 1118, 1035cm-¹. ¹H NMR (400 MHz, CDCl3): δ = 7.86-6.53 (m, 19 H, ArH), 6.23 (s, 1 H, ArH), 4.14 (q, J = 7.0 Hz, 2 H, OCH2), 1.45 (t, J = 7.0 Hz, 3 H, CH3). MS: m/z (%) = 464 (100) [M+], 435 (65), 380 (92), 277 (18), 261 (10), 201 (11), 183 (16), 145 (16). Anal. Calcd for C29H25N2O2P: C, 74.99; H, 5.42; N, 6.03. Found: C, 74.77; H, 5.60; N, 6.12.
13
Oxazolo[3,2-
c
]quinazolines
8
To a solution of iminophosphorane 6 (0.46
g, 1 mmol) in dry CH2Cl2 (10 mL) was added
aryl isocyanate (1 mmol) under nitrogen at r.t. The solution turned
red immediately. After stirred for 1 h, the solvent was evaporated
under reduced pressure, and the residue was recrystallized from
Et2O and EtOH (1:1, v/v) to give oxazolo[3,2-c]quinazolines 8 as
red crystals.
Compound 8a: red
crystals, mp 151 ˚C (dec.). IR (KBr): 1764, 1690, 1640,
1560, 1474, 1440, 1307, 1251 cm-¹.
¹H
NMR (400 MHz, CDCl3): δ = 7.68-6.94
(m, 10 H, ArH), 4.39 (q, J = 7.0
Hz, 2 H, OCH2), 1.58 (t, J = 7.0
Hz, 3 H, CH3). ¹³C NMR (150
MHz, CDCl3): δ = 157.5,
153.2, 150.8, 147.2, 143.4, 135.5, 129.1, 128.4, 125.6, 123.3, 121.7, 120.4,
102.7, 87.9, 70.5, 14.3. MS: m/z (%) = 305
(53) [M+], 248 (29), 231 (100),
205 (60), 166 (15), 104 (10), 90 (22). Anal. Calcd for C18H15N3O2:
C, 70.81; H, 4.95; N, 13.76. Found: C, 70.90; H, 4.99; N, 13.91.
Compound 8b: red crystals, mp 105-107 ˚C.
IR (KBr): 1765, 1689, 1639, 1605, 1471, 1442, 1219, 1165 cm-¹.
¹H
NMR (400 MHz, CDCl3): δ = 7.62-6.78
(m, 9 H, ArH), 4.34 (q, J = 7.0
Hz, 2 H, OCH2), 2.35 (s, 3 H, CH3), 1.56 (t, J = 7.0 Hz,
3 H, CH3). ¹³C NMR (150
MHz, CDCl3): δ = 157.4,
153.6, 150.8, 148.2, 143.6, 137.8, 135.3, 128.1, 125.4, 124.0, 122.2,
121.6, 120.3, 119.8, 102.3, 87.7, 70.3, 21.6, 14.2. MS: m/z (%) = 319
(6) [M+], 291 (100), 262 (13), 248
(46), 235 (28), 91 (5). Anal. Calcd for C19H17N3O2:
C, 71.46; H, 5.37; N, 13.16. Found: C, 71.59; H, 5.50; N, 13.20.
Compound 8c: red crystals, mp 157 ˚C (dec.).
IR (KBr): 1642, 1605, 1558, 1530, 1478, 1441, 1308, 1254, 1032
cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 7.64-6.92
(m, 9 H, ArH), 4.33 (q, J = 7.2
Hz, 2 H, OCH2), 1.56 (t, J = 7.2
Hz, 3 H, CH3). ¹³C
NMR (100 MHz, CDCl3): δ = 157.6,
152.8, 150.6, 135.7, 129.9, 128.2, 128.1, 126.1, 125.5, 124.4, 121.7,
121.0, 102.9, 88.0, 70.6, 14.3. MS: m/z (%) = 339 (100) [M+],
311 (68), 265 (88), 255 (81), 230 (53), 192 (10), 125 (24). Anal.
Calcd for C18H14ClN3O2:
C, 63.63; H, 4.15; N, 12.37. Found: C, 63.89; H, 4.22; N, 12.51.
Compound 8d: red crystals, mp 156 ˚C (dec.).
IR (KBr): 1665, 1644, 1610, 1562, 1485, 1441, 1308, 1207, 1032
cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 7.65-6.89
(m, 9 H, ArH), 4.36 (q, J = 7.0
Hz, 2 H, OCH2), 1.57 (t, J = 7.0
Hz, 3 H, CH3). ¹³C
NMR (100 MHz, CDCl3): δ = 159.1,
157.4, 156.7, 153.7, 144.7, 143.8, 135.4, 125.3, 124.5, 124.5, 121.7,
119.8, 114.8, 114.6, 102.3, 87.6, 70.3, 14.3. MS:
m/z (%) = 323
(32) [M+], 295 (26), 266 (33),
250 (100), 239 (89), 223 (36), 125 (45). Anal. Calcd for C18H14FN3O2:
C, 66.87; H, 4.36;N, 13.00. Found: C, 66.73; H, 4.54; N, 13.25.
Oxazolo[3,2- c ]quinazoline 10 To a solution of iminophosphorane 6 (0.46 g, 1 mmol) in MeCN (10 mL) was added CS2 (1.50 g, 20 mmol). The mixture was heated to reflux for 10 h, the solvent was evaporated under reduced pressure, and the residue was recrystallized from EtOH to give oxazolo[3,2-c]quinazoline 10; yellow crystals, mp 138-139 ˚C. IR (KBr): 1654, 1635, 1484, 1434, 1321, 1298, 1176, 1054 cm-¹. ¹H NMR (400 MHz, CDCl3): δ = 7.94-7.38 (m, 5 H, ArH), 4.47 (q, J = 7.2 Hz, 2 H, OCH2), 1.61 (t, J = 7.2 Hz, 3 H, CH3). ¹³C NMR (100 MHz, CDCl3): δ = 157.4, 148.4, 138.4, 135.7, 128.2, 126.8, 125.0, 121.5, 115.5, 91.3, 71.0, 14.2. MS: m/z (%) = 246 (37) [M+], 218 (25), 190 (28), 162 (100), 134 (34). Anal. Calcd for C12H10N2O2S: C, 58.52; H, 4.09; N, 11.37. Found: C, 58.59; H, 4.21; N, 11.41.